TLR7 and breast carcinoma: This study aims to explore the individual effects of TLR7/8 agonists and to compare their cytotoxic properties with those of the chemotherapy drug doxorubicin on 4T1 breast cancer cells, as well as to evaluate their role in the modulation of immune checkpoint molecules.